LEVANGIE DANIEL J has filed 5 insider transactions across 2 companies since November 2023.
Most recent transaction: a grant/award of 5398 shares of EXACT SCIENCES CORP ($EXAS) on June 12, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | EXACT SCIENCES CORP | $EXAS | LEVANGIE DANIEL J | Not found | A | Common Stock | 5398 | $0.00 | 34,312.0000 | 185,755,406 | 18.67% | 0.00% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | LEVANGIE DANIEL J | Not found | A | Common Stock | 5939 | $0.00 | 28,914.0000 | 0 | 25.85% | 0.00% |
| June 13, 2024 | EXACT SCIENCES CORP | $EXAS | LEVANGIE DANIEL J | Not found | A | Common Stock | 5444 | $0.00 | 28,419.0000 | 0 | 23.70% | 0.00% |
| March 1, 2024 | EXACT SCIENCES CORP | $EXAS | LEVANGIE DANIEL J | Director | S | Common Stock | 5000 | $57.50 | 22,975.0000 | 0 | 17.87% | 0.00% |
| Nov. 20, 2023 | Renalytix plc | $RENXF | LEVANGIE DANIEL J | Director | A | Employee Stock Option (right to buy) | 95000 | $0.00 | 95,000.0000 | 0 | 9999.99% | 0.00% |